Stock research firms currently have a positive stance on shares of uniQure N.V. (NASDAQ:QURE). Analysts are projecting that the stock will reach $14.24 on a short term (1 year) basis.
The majority of analysts covering the equity have either a Buy or Strong Buy recommendation on the stock, yielding a consensus score of 1.40. This is based on the research brokerage reports taken into consideration by Thomson Reuters.
At the time of writing, the stock was trading at $11.32. This represents a change from most recent open price of 3.47%. In terms of performance, year to date, the stock is 95.71%. The monthly stock performance comes in at 29.86%. For the quarter, shares are performing at 65.56%. Weekly performance analysis shows the equity at 9.27%.
In taking a look at technical levels, shares are trading 30.32% away from the 50 day simple moving average and 71.20% away from the 200 day simple moving average. Based on a recent bid, the stock is trading 2.35% away from it’s 52- week high and 139.83% away from its 52 week low. After the recent moves, investors may also look to see if the stock has entered oversold or overbought territory and could be ripe for a bounce. As of writing, uniQure N.V.’s RSI stands at 71.32. In looking at volatility levels, the shares saw weekly volatility of 4.90% and 6.36% over the past month.
Brokerage firms currently have a positive stance on shares of Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD). The majority of analysts covering the equity have either a Buy or Strong Buy recommendation on the stock, yielding a consensus score of 2.00. Those same analysts are projecting that the stock will reach $16.00 on a short term basis.
Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) shares typically trade an average volume of 36.56 and institutions hold 8.40% of the total shares.
We see here that the stock is 5.15% away from the 20-Day Simple Moving Average. Their 50-Day Simple Moving Average is a difference of 12.44% from current levels. Further back, their 200-Day Simple Moving Average is 57.08% difference from today’s price. Currently, the stock is -4.17% from its 50-Day High and 36.35% from the 50-day low.
Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD)‘s stock has performed at 153.56%. Breaking that down further, it has performed 1.02% for the week, 14.10% for the month, 30.88% over the last quarter, 76.70% for the past half-year and 102.27% for this last year.